• Return to Headlines

43.5% Return Seen to Date on SmarTrend Genomic Health I Call (GHDX)

By Amy Schwartz

SmarTrend identified an Uptrend for Genomic Health I (NASDAQ:GHDX) on May 7th, 2018 at $35.33. In approximately 1 month, Genomic Health I has returned 43.50% as of today's recent price of $50.70.

In the past 52 weeks, Genomic Health I share prices have been bracketed by a low of $24.81 and a high of $53.65 and are now at $50.81, 105% above that low price. The 200-day and 50-day moving averages have moved 0.93% higher and 3.31% higher over the past week, respectively.

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company's diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Genomic Health I shares.

Log in and add Genomic Health I (GHDX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights genomic health i

Ticker(s): GHDX